Derivative exercise or conversion — not an open-market buy.
Traded Sep 1, 2026 · Filed Sep 3, 2026
Charles Schwab Corporation's MD, Head Wealth Adv, Bnk, Tst sold $346K of Charles Schwab Corporation shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$346,428
Shares × reported transaction price
42 days after results of Jul 21, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $108.28 on Sep 1, 2026, within 5% of its 52-week high, after an 8% rise over the previous 30 trading days
52-week range $85.35 (May 28, 2026) to $113.65 (Aug 24, 2026), 81% of the way up, from 252 adjusted closes. 30 trading days earlier: $99.96 on Jul 21, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Oct 6, 2025 in the U.S. District Court, E.D. Texas. A filing is an allegation, not a finding.
Lewis v. Charles Schwab & Co., Inc., docket 4:25-cv-01086, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -2.8% | -2.0% | -0.8% |
| 30 days | -11.3% | +0.2% | -11.5% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.